Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Topical minoxidil showed promise for early male pattern baldness.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Adipokines affect skin health and could be targeted for treating skin diseases.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.